
Garen Gotfredson
Examiner (ID: 3455, Phone: (571)270-3468 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 667 |
| Issued Applications | 237 |
| Pending Applications | 89 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18389826
[patent_doc_number] => 20230158044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => MONOLITHIC INTRAVAGINAL RINGS COMPRISING PROGESTERONE AND METHODS OF MAKING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/857959
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857959 | MONOLITHIC INTRAVAGINAL RINGS COMPRISING PROGESTERONE AND METHODS OF MAKING AND USES THEREOF | Jul 4, 2022 | Abandoned |
Array
(
[id] => 19387775
[patent_doc_number] => 20240277645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => CONTINOUS IMPREGNATION OF ACTIVE PHARMACEUTICAL INGREDIENTS ONTO POROUS CARRIERS
[patent_app_type] => utility
[patent_app_number] => 18/571083
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571083
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/571083 | CONTINOUS IMPREGNATION OF ACTIVE PHARMACEUTICAL INGREDIENTS ONTO POROUS CARRIERS | Jun 12, 2022 | Pending |
Array
(
[id] => 17865225
[patent_doc_number] => 20220287960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => SUSTAINED RELEASE ESTROGEN VAGINAL RING PESSARY FOR TREATMENT OF ATROPHY, CYSTITIS AND UTEROVAGINAL PROLAPSE
[patent_app_type] => utility
[patent_app_number] => 17/829702
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/829702 | Sustained release estrogen vaginal ring pessary for treatment of atrophy, cystitis and uterovaginal prolapse | May 31, 2022 | Issued |
Array
(
[id] => 19297829
[patent_doc_number] => 20240226395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => COATING FOR MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/563331
[patent_app_country] => US
[patent_app_date] => 2022-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563331 | COATING FOR MEDICAL DEVICES | May 29, 2022 | Pending |
Array
(
[id] => 19246614
[patent_doc_number] => 20240197598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => AMINO ACID SCALP AND HAIR CARE COMPOSITION, SCALP AND HAIR CARE PRODUCT CONTAINING SAID COMPOSITION AND PREPARATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/574435
[patent_app_country] => US
[patent_app_date] => 2022-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574435
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/574435 | AMINO ACID SCALP AND HAIR CARE COMPOSITION, SCALP AND HAIR CARE PRODUCT CONTAINING SAID COMPOSITION AND PREPARATION METHOD | May 29, 2022 | Pending |
Array
(
[id] => 17850597
[patent_doc_number] => 20220280638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => METHODS AND ARTICLES FOR ALLERGIC DESENSITIZATION VIA THE ORAL MUCOSA
[patent_app_type] => utility
[patent_app_number] => 17/740878
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740878 | METHODS AND ARTICLES FOR ALLERGIC DESENSITIZATION VIA THE ORAL MUCOSA | May 9, 2022 | Abandoned |
Array
(
[id] => 19297455
[patent_doc_number] => 20240226020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => SOTORASIB FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/558827
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558827 | SOTORASIB FORMULATION | May 4, 2022 | Pending |
Array
(
[id] => 17928408
[patent_doc_number] => 20220323533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMPOSITION FOR PREVENTING, INHIBITING OR TREATING INFECTION OF CORONAVIRUS
[patent_app_type] => utility
[patent_app_number] => 17/714769
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714769 | COMPOSITION FOR PREVENTING, INHIBITING OR TREATING INFECTION OF CORONAVIRUS | Apr 5, 2022 | Abandoned |
Array
(
[id] => 17733412
[patent_doc_number] => 20220218871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => MEDICAL DEVICE WITH A BIOCOMPATIBLE COATING
[patent_app_type] => utility
[patent_app_number] => 17/710491
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710491 | MEDICAL DEVICE WITH A BIOCOMPATIBLE COATING | Mar 30, 2022 | Abandoned |
Array
(
[id] => 17911216
[patent_doc_number] => 20220313611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => METHODS TO PREPARE DRY POWDERS USING SUSPENSION BASED THIN FILM FREEZING
[patent_app_type] => utility
[patent_app_number] => 17/693062
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693062
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693062 | METHODS TO PREPARE DRY POWDERS USING SUSPENSION BASED THIN FILM FREEZING | Mar 10, 2022 | Pending |
Array
(
[id] => 19324705
[patent_doc_number] => 12042357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Bellows bandage drug delivery system
[patent_app_type] => utility
[patent_app_number] => 17/691897
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 861
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691897 | Bellows bandage drug delivery system | Mar 9, 2022 | Issued |
Array
(
[id] => 17981121
[patent_doc_number] => 20220347157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING (1R, 5S)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE
[patent_app_type] => utility
[patent_app_number] => 17/691911
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691911 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING (1R, 5S)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE | Mar 9, 2022 | Abandoned |
Array
(
[id] => 20700307
[patent_doc_number] => 12622998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-12
[patent_title] => Liquid dressing
[patent_app_type] => utility
[patent_app_number] => 17/691660
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691660
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691660 | Liquid dressing | Mar 9, 2022 | Issued |
Array
(
[id] => 19535532
[patent_doc_number] => 12128065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Composition and methods for generating and sustaining molecular hydrogen (H
[patent_app_type] => utility
[patent_app_number] => 17/685644
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 32615
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685644
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/685644 | Composition and methods for generating and sustaining molecular hydrogen (H | Mar 2, 2022 | Issued |
Array
(
[id] => 17828601
[patent_doc_number] => 20220265905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => Polyurethane Based Medical Articles
[patent_app_type] => utility
[patent_app_number] => 17/680657
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680657 | Polyurethane based medical articles | Feb 24, 2022 | Issued |
Array
(
[id] => 18374234
[patent_doc_number] => 20230149311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => PHARMACEUTICAL COMPOSITION OF LIPID NANOPARTICLE FOR DELIVERING NUCLEIC ACID DRUG CONTAINING TREHALOSE DERIVATIVE AND NOVEL STRUCTURE-MAINTAINING LIPID COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/676822
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676822 | Pharmaceutical composition of lipid nanoparticle for delivering nucleic acid drug containing trehalose derivative and novel structure-maintaining lipid compound | Feb 21, 2022 | Issued |
Array
(
[id] => 19096265
[patent_doc_number] => 20240115492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => AN ORODISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORM OF RASAGILINE
[patent_app_type] => utility
[patent_app_number] => 18/262867
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262867
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262867 | AN ORODISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORM OF RASAGILINE | Jan 27, 2022 | Pending |
Array
(
[id] => 20218482
[patent_doc_number] => 20250281413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/261523
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261523
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261523 | PHARMACEUTICAL COMPOSITION | Jan 23, 2022 | Pending |
Array
(
[id] => 17593354
[patent_doc_number] => 20220142927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 17/580991
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580991 | TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | Jan 20, 2022 | Abandoned |
Array
(
[id] => 17748024
[patent_doc_number] => 20220226227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => DISSOLVABLE SOLID ARTICLE CONTAINING PRESERVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/580180
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580180
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580180 | Dissolvable solid article containing preservatives | Jan 19, 2022 | Issued |